Literature DB >> 7780098

Tracing as part of tuberculosis control in a rural Cambodian district during 1992.

M E Kimerling1, L Petri.   

Abstract

SETTING: The rural Cambodian district of Banteay Meas, population 74,464.
OBJECTIVE: To evaluate the effectiveness of a district based tracing program developed to improve tuberculosis control program treatment results. Specifically, to assess factors affecting patient non-adherence to therapy and return of patients to treatment.
DESIGN: All patients started on treatment during 1992 were included. Standardized cohort analysis methods were applied to assess treatment outcome for all tuberculosis cases registered during Trimesters I-III. Absconders for the year were traced and followed as a separate cohort. Those returning to therapy were followed until the end of the study period in October 1993.
RESULTS: Activity in 1992 included 171 admissions and 46 absconders. Of the 46, 57% were met at home. Among those met, 81% returned to treatment. Males absconded more than females even though females accounted for a majority of admissions. Socioeconomic factors (68%) were cited most often as the reason for non-adherence. Distance was not a factor. Cohort analysis showed improvement in the treatment completion rate (54.8% vs 69.2% vs 64%) coupled with a drop in the absconding rate (35.5% vs 25% vs 20%). Of the 21 patients returning, 76% have either completed or nearly completed treatment.
CONCLUSION: These results support tracing as an effective means to improve patient adherence in rural Cambodia, thereby strengthening tuberculosis control programs at district level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780098     DOI: 10.1016/0962-8479(95)90559-6

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  1 in total

1.  Predictors of adherence to antiretroviral therapy in rural Zambia.

Authors:  James G Carlucci; Aniset Kamanga; Robb Sheneberger; Bryan E Shepherd; Cathy A Jenkins; John Spurrier; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.